Observational studyMedicine2025
Study on a 28-day prognostic model for ICU patients with AB infection based on machine learning.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to establish 28-day prognostic model for intensive care unit (ICU) patients with Acinetobacter baumannii (AB) infection based on machine learning. This retrospective study collected clinical data of patients admitted to the Intensive Care Medicine Department (ICU) of the Second Hospital of Nanjing from March 2021 to October 2023. The data underwent univariate and multivariate COX survival analysis, Lasso regression analysis, survival curve analysis, and model construction with SPSS and R language. The model was evaluated with area under the curves, calibration curves, and decision curve analysis curves to assess its clinical utility. Univariate COX survival analysis revealed that 11 variables: hormones, sequential organ failure assessment (SOFA), CD4 T, ThTsCD4CD8, hospital-acquired pneumonia, ventilator-associated pneumonia, pro-procalcitonin, pro-interleukin-6 (IL-6), procalcitonin, IL-6, and duration of mechanical ventilation (DurationMV) were significant risk factors for mortality in AB-infected patients (P < .05). In the Lasso regression analysis, lambda.1se (0.147) was selected as the optimal λ value. Variable selection was performed with the K-fold cross-validation method in the glmnet package, involving 9 influencing factors including albumin, acute physiology and chronic health evaluation II, CD4.T, SOFA, hospital-acquired pneumonia, ventilator-associated pneumonia, pro-IL6, IL-6, and DurationMV. An epwise Cox regression model was established with a global Schoenfeld test value of 0.1629. The mean square difference between survival probabilities and actual results was consistently <0.25, indicating accurate model predictions. Based on above-mentioned factors, multivariate Cox analysis showed that SOFA and DurationMV were independent risk factors for fatal outcomes, with no correlation between variables and variance inflation factor values <5. Grouping based on SOFA score showed statistically significant differences in mortality rates (P < .05), with higher scores associated with shorter survival times. DurationMV had greater prognostic value than the SOFA "score," enhancing academic accuracy. Using DurationMV and SOFA variables, a survival analysis line chart model for 7, 14, and 28 days was constructed. The model was validated on 147 patients randomly divided into a training set and a validation set, achieving an area under the curve of over 80%, with calibration curves close to the diagonal line, indicating relative stability in predicting the 28-day prognosis of AB-infected patients. A 28-day prognostic model for ICU patients with AB infection based on machine learning was successfully developed and its value validated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.